Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
Current Opinion in Clinical Nutrition & Metabolic Care, 06/26/2012
Schugar RC et al. – Because low–carbohydrate ketogenic diets are increasingly employed for treatment of obesity, nonalcoholic fatty liver disease (NAFLD), and neurological diseases such as epilepsy, understanding the long–term systemic effects of low–carbohydrate diets is crucial to the development of efficacious and safe dietary interventions.



